Investigations to Assess the Role of Glucagon Signaling in Healthspan and Aging

NIH RePORTER · NIH · R00 · $119,976 · view on reporter.nih.gov ↗

Abstract

Calorie restriction increases liver 5’AMP kinase (AMPK) activity. Like the glucagon receptor, AMPK is essential for calorie restriction to extend lifespan and healthspan. Because AMPK is downstream of glucagon receptor signaling it is possible that glucagon receptor activated AMPK is necessary for calorie restriction to improve healthspan We propose that glucagon receptor signaling at the liver, which increases with both calorie restriction and obesity, slows aging dependent upon glucagon receptor stimulated AMPK activity. The proposed study will extend our findings from the parent grant to assess the ability to rescue the impaired healthspan in glucagon receptor null mice by inducing hepatocyte expression of a constitutively active AMPK.

Key facts

NIH application ID
10600274
Project number
3R00AG055649-05S1
Recipient
UNIVERSITY OF ARIZONA
Principal Investigator
JENNIFER HELENE STERN
Activity code
R00
Funding institute
NIH
Fiscal year
2022
Award amount
$119,976
Award type
3
Project period
2017-08-15 → 2023-05-31